Loading clinical trials...
Loading clinical trials...
An Open, Phase III, Multicentre, 52-week Study, Evaluating the Safety and Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With Asthma
Conditions
Interventions
Budesonide/Formoterol
Locations
18
Japan
Research Site
Komaki, Aichi-ken, Japan
Research Site
Seto, Aichi-ken, Japan
Research Site
Gifu, Gifu, Japan
Research Site
Ōwa, Gunma, Japan
Research Site
Hiroshima, Hiroshima, Japan
Research Site
Sapporo, Hokkaido, Japan
Start Date
November 1, 2005
Primary Completion Date
December 1, 2006
Completion Date
June 1, 2007
Last Updated
January 24, 2011
NCT07219173
NCT07486401
NCT02327897
NCT04706988
NCT04639791
NCT06471257
Lead Sponsor
AstraZeneca
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions